Firms
Theme

MELI

Mercado Libre, Inc · NASDAQ

News

17 latest

The Motley Fool

Mercado Libre Stock Analysis: Buy, Hold, or Sell?

Mercado Libre's growth is being boosted by a more affordable shipping program. The article analyzes whether the stock is a buy, hold, or sell opportunity, highlighting Latin America's strong economic growth prospects compared to developed markets.

Zacks Investment Research

MercadoLibre (MELI) Declines More Than Market: Some Information for Investors

MercadoLibre closed down 1.16%, underperforming the S&P 500's 1.09% decline. The stock has gained 1.74% over the past month but trades at a premium valuation with a Forward P/E of 48.7 versus its industry's 15.65. While earnings are expected to grow 13.22% next quarter and revenue 43.61%, the Zacks Rank downgraded to #3 (Hold) following a 2.51% downward revision in consensus EPS estimates over the past month.

Zacks Investment Research

Should You Buy, Sell or Hold MELI Stock at a P/S Valuation of 1.83X?

MercadoLibre (MELI) trades at 1.83X forward sales, below its historical median, with Q2 2026 revenues surging 50% to $10.2B driven by Commerce and fintech growth. However, operating margins contracted to 6.7%, and mixed earnings estimates—with current-year EPS declining 3.2% but next-year growth expected at 44.9%—support a hold stance amid profitability concerns and macroeconomic uncertainties.

Zacks Investment Research

MercadoLibre's Commerce-Fintech Flywheel Gains Strength

MercadoLibre reported a 37% year-over-year surge in ecosystemic users who engage with both its marketplace and Mercado Pago financial services. These integrated users generated 70% more gross merchandise volume and purchased 55% more items than marketplace-only users.

Zacks Investment Research

MercadoLibre (MELI) Outperforms Broader Market: What You Need to Know

MercadoLibre (MELI) closed at $1,889.29, up 1.76% in the latest session. The stock has declined 2.6% over the past month.

Zacks Investment Research

MercadoLibre (MELI) Stock Falls Amid Market Uptick: What Investors Need to Know

MercadoLibre stock declined 2.51% to $1,685.12, underperforming the broader market which posted modest gains. The stock has fallen 13.86% over the past month, significantly underperforming its sector. While earnings growth is expected at 13.22% for the upcoming quarter with revenue projected to grow 43.61%, the company carries a Zacks Rank #4 (Sell) rating and trades at a premium valuation with a Forward P/E of 44.19 compared to its industry average of 15.4.

Zacks Investment Research

MercadoLibre's Credit Growth Strengthens Its Fintech Ecosystem

MercadoLibre's credit business expanded significantly in Q2 2026, with its credit portfolio reaching $16.4 billion (75% YoY growth) and 2.6 million new credit cards issued. The company maintained strong credit quality with NPLs near historical lows. However, MELI stock has underperformed its industry peers over the past three months and carries a Zacks Rank #4 (Sell) rating, trading at a premium valuation despite mixed earnings outlook.

Mentions MELI

The Motley Fool

Breakfast News: Week in Review

Meta, SpaceX, and Tesla posted strong revenue but are spending heavily on AI infrastructure with uncertain cash flow outcomes. Walmart opened AI shopping to approved agents while Amazon blocked them.

The Motley Fool

Breakfast News: A One-Line Fix Could Shake Up AI

Amazon released TorchNeuron, an open-source software tool that allows PyTorch code to run on AWS Trainium chips with minimal changes, challenging Nvidia's market dominance. Amazon stock surged 5% on the announcement.

The Motley Fool

Nebius and 3 Other Stocks I Don't Mind Buying Before 2026 Ends

Neil Rozenbaum recommends four stocks worth considering before the end of 2026: Nebius, Meta Platforms, MercadoLibre, and Nu Holdings. The article highlights why these companies made his investment list, though specific reasoning details are not fully elaborated in the provided content.

The Motley Fool

Chewy vs. MercadoLibre: Which E-Commerce Stock Is a Better Buy in 2026?

The article compares Chewy, a U.S. online pet retailer, and MercadoLibre, a Latin American e-commerce and fintech platform. MercadoLibre shows stronger revenue growth at 39.1% in 2025 versus Chewy's 6.2%, but both face challenges: Chewy has thin margins and single-digit growth, while MercadoLibre sacrifices profitability for expansion and faces credit risks. The author favors MercadoLibre as a long-term buy despite volatility, while viewing Chewy as steadier but requiring veterinary acquisitions to prove value.

The Motley Fool

Alibaba vs. MercadoLibre: Which Stock Is a Better Buy in 2026?

Alibaba and MercadoLibre represent two distinct investment paths: Alibaba offers deep value with a P/E of 24.61 and strong cloud/AI growth in China, while MercadoLibre trades at a premium P/E of 51.05 but delivers hyper-growth at 39.1% YoY in Latin America's emerging fintech and e-commerce markets. The author recommends MercadoLibre for patient investors seeking exposure to early-stage digital adoption, despite geopolitical risks favoring Alibaba's valuation.

The Motley Fool

Coupang vs. MercadoLibre: Which Consumer Stock Is a Better Buy in 2026?

MercadoLibre emerges as the superior investment choice compared to Coupang, driven by significantly higher revenue growth (39.1% vs 14.1%), superior profitability (6.9% net margin vs 0.6%), and a much larger customer base across 18 countries. While Coupang trades at a lower valuation multiple, MercadoLibre's robust cash flow generation and expanding fintech ecosystem provide better long-term value despite operating in volatile emerging markets.

Zacks Investment Research

Can MercadoLibre's Cross-Border Trade Drive Its Next Growth Phase?

MercadoLibre reported strong cross-border trade (CBT) momentum in Q2 2026, with GMV up 60% year-over-year on a currency-neutral basis. Mexico led CBT growth, while Argentina and Brazil achieved triple-digit growth.

The Motley Fool

Here Are My Top 4 Stocks to Buy in October

The article recommends four stocks for October investment: Viking Therapeutics for its unique monthly-dose GLP-1 weight loss drug candidate in a market expected to reach $200 billion by 2030; Alphabet for its dominant position in cloud computing AI services with 82% YoY growth and gaining market share; SoFi Technologies for strong revenue growth (40% YoY) and customer expansion despite recent setbacks; and MercadoLibre for its Amazon-like growth trajectory in Latin America with 50% YoY revenue growth despite margin pressures from free shipping initiatives.

The Motley Fool

10 Top Stocks I'd Buy Right Now

Following the Federal Reserve's first rate increase in three years, Matt Frankel presents a curated list of 10 stocks to buy now, featuring a mix of safe compounders, dividend payers, and higher-upside growth names suitable for various investor types.

The Motley Fool

58% of Americans Own Stock, but Most Are Doing It Wrong. I'd Start With These 2 Names Instead.

While 58% of Americans own stocks, most invest in broad index funds or trendy sectors like AI, missing better opportunities. The article recommends MercadoLibre, a Latin American e-commerce and fintech platform with 6,200% historical returns and 36% GMV growth, and Sprouts Farmers Market, a health-focused grocer trading at a cheap P/E of 13 with strong buyback programs and 500% EPS growth over 10 years.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $MELI · 0 threads

Sign in to post on $MELI

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev